Brief: AlphaHelix delivers MRSA-platform to Finland

Level Bio AB (publ)

22/06/2016 13:54

June 22 (Reuters) - Alphahelix Molecular Diagnostics publ AB  ALHX.ST : 
    * Subsidiary Techtum Lab will in the coming week to set up a system for screening of MRSA in 
Tampere, Finland 
    * Assuming that validation in Finland goes according to plan, the deal will give revenues of 
2 million Swedish crowns ($242,078.00) per year for the group 
    * The contract period is 3-5 years 
 
     
 Source text: http://bit.ly/28MxqL5 
     
 Further company coverage:  ALHX.ST   
    
 
 
 
($1 = 8.2618 Swedish crowns) 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))